Serum alkaline phosphatase level in acromegaly patients and an association with its level in saliva]

Authors

Shiamaa Mohammad Zwain, Specialist Dentist in the Specialized Dental Centre,Follow
Sahar Hamdan Alani, Dean of the College of Dentistry, University of Baghdad
Shiamaa Mohammad Huthiafa Alrubaie, Specialist Dentist in the Specialized Dental Centre.
Najla Mohammad Zwain, Senior Manager, Najaf Governorate Office,

Abstract

OBJECTIVE: The study aimed to determine the levels of bone turn over biomarker (ALP) in Iraqi acromegaly patients in addition to find the relationship between these levels in serum and saliva. METHODS: In this cross-sectional study, 20 healthy controls (10 female and 10 male) and 40 patients with acromegaly (22 female and 18 male) who were visiting the National Centre for Diabetes and Endocrinology / AL- Mustansiriya University / Baghdad were included. Every patient was prescribed an octreotide somatostatin analog medication after being diagnosed by a hospital doctor. For both groups, the levels of alkaline phosphatase (ALP) in serum and saliva were measured. RESULTS: The acromegaly group had higher mean values of serum and salivary ALP than the control group (p=0.01, p

Recommended Citation

Zwain, Shiamaa Mohammad; Alani, Sahar Hamdan; Alrubaie, Shiamaa Mohammad Huthiafa; and Zwain, Najla Mohammad (2024) "Serum alkaline phosphatase level in acromegaly patients and an association with its level in saliva]," Maaen Journal for Medical Sciences: Vol. 3 : Iss. 1 , Article 8.
Available at: https://doi.org/10.55810/2789-9136.1042

References

[1] Katznelson L, Laws Jr ER, Melmed S, Molitch ME, Murad MH, Utz A, et al. Guideline. J Clin Endocrinol Metab 2014 Nov;99(11):3933-51. https://doi.org/10.1210/jc.2014- 2700. Epub 2014 Oct 30. PMID: 25356808.

[2] Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, et al. A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 2013 Sep;16(3):294-302. https://doi.org/10.1007/s11102-012- 0420-x. PMID: 22903574; PMCID: PMC3730092.

[3] Dineen R, Stewart Paul M, Sherlock M. Acromegaly QJM: Int J Med 2016 July;110(7):411-20. https://doi.org/10.1093/ qjmed/hcw004.

[4] Lieberman SA, Bj€orkengren AG, Hoffman AR. Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin N Am 1992 Sep 21;(3):615-31. PMID: 1521515.

[5] Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin- like growth factors, and the skeleton. Endocr Rev 2008 Aug;29(5):535-59. https://doi.org/10.1210/er.2007-0036. Epub 2008 Apr 24. PMID: 18436706; PMCID: PMC2726838.

[6] Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview. Indian J Clin Biochem 2014 Jul;29(3):269-78. https:// doi.org/10.1007/s12291-013-0408-y. Epub2013Nov 26. PMID: 24966474; PMCID: PMC4062654.

[7] Leeming DJ, Koizumi M, Byrjalsen I, Li B, Qvist P, Tanko LB. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Cancer Epidemiol Biomarkers Prev 2006 Jan;15(1):32-8. https://doi.org/10.1158/ 1055-9965.EPI-05-0492. PMID: 16434583.

[8] Rao SR, Snaith AE, Marino D, Cheng X, Lwin ST, Orriss IR, et al. Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer. Br J Cancer 2017 Jan 17;116(2): 227-36. https://doi.org/10.1038/bjc.2016.402. Epub 2016 Dec 22. PMID: 28006818; PMCID: PMC5243990.

[9] Iba K, Takada J, Yamashita T. The serum level of bonespecific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metabol 2004;22(6):594-6. https://doi.org/10.1007/s00774-004-0528-9. PMID: 15490270.

10] Saraç F, Nsaygõlõ F. Causes of High Bone Alkaline Phosphatase. Biotechnol Biotechnol Equip 2007;21(2):194-7. https://doi.org/10.1080/13102818.2007.10817444.

[11] Butch AW, Goodnow TT, Brown WS, McClellan A, Kessler G, Scott MG. Stratus automated creatine kinase-MB assay evaluated: identification and elimination of falsely increased results associated with a high-molecular-mass form of alkaline phosphatase. Clin Chem 1989 Oct;35(10): 2048-53. PMID: 2676240.

[12] Vimalraj S. Alkaline phosphatase: Structure, expression and its function in bone mineralization. Gene 2020 Sep 5;754: 144855. https://doi.org/10.1016/j.gene.2020.144855. Epub 2020 Jun 6. PMID: 32522695.

[13] Farnaud SJ, Kosti O, Getting SJ, Renshaw D. Saliva: physiology and diagnostic potential in health and disease. Sci World J 2010 Mar 16;10:434e56. https://doi.org/10.1100/tsw. 2010.38. PMID: 20305986; PMCID: PMC5763701.

[14] Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent 2009 Aug;22(4):241-8. PMID: 19824562; PMCID: PMC2860957.

[15] Castagnola M, Picciotti PM, Messana I, Fanali C, Fiorita A, Cabras T, et al. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital 2011 Dec;31(6): 347-57. DOI: PMID: 22323845; PMCID: PMC3272865.

[16] Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 2005 Nov; 26(4):97-122. DOI: PMID: 16648882; PMCID: PMC1320175.

[17] van Straalen JP, Sanders E, Prummel MF, Sanders GT. Bonealkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991 Sep 14;201(1-2):27-33. https://doi.org/10. 1016/0009-8981(91)90021-4. PMID: 1790624.

[18] Marazuela M, Astigarraga B, Tabuenca MJ, Estrada J, Marín F, Lucas T. Serum bone Gla protein as a marker of bone turnover in acromegaly. Calcif Tissue Int 1993 Jun; 52(6):419-21. https://doi.org/10.1007/BF00571329. PMID: 8369987.

[19] Piskinpasa ME, Piskinpasa H. Bone biochemical markers in acromegaly: An association with disease activity and gonadal status. North Clin Istanb 2022 Feb 10;9(1):74-81. https://doi. org/10.14744/nci.2020.35467. PMID: 35340319; PMCID: PMC8889209.

[20] Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 1993 Jun;76(6):1452-7. https://doi.org/10.1210/jcem.76.6.8501150. PMID: 8501150.

[21] Piovesan A, Terzolo M, Reimondo G, Pia A, Codegone A, Osella G, et al. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res 1994 May;26(5):234-7. https://doi.org/10.1055/s- 2007-1001672. PMID: 8076906.

[22] Legovini P, De Menis E, Breda F, Billeci D, Carteri A, Pavan P, et al. Long-term effects of octreotide on markers of bone metabolism in acromegaly: evidence of increased serum parathormone concentrations. J Endocrinol Invest 1997 Sep;20(8):434-8. https://doi.org/10.1007/BF03347998. PMID: 9364245.

[23] Bolanowski M, Daroszewski J, Medra_s M, Zadrozna- Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metabol 2006;24(1):72-8. https://doi. org/10.1007/s00774-005-0649-9. PMID: 16369902.

[24] Morselli LL, Manetti L, Cosci C, Sardella C, Bogazzi F, Faldini C, et al. Bone and joint alterations in acromegaly. J Orthop Traumatol 2006 Dec;7(4):169-75. https://doi.org/10. 1007/s10195-006-0143-8. Epub 2006 Dec 18. PMCID: PMC4901205.

[25] Abass Eiman A, Abed Baydaa A, Mohsin Sohaib N. Determination of Osteocalcin, Bone Alkaline Phosphatase, and Lysyl Oxidase in Iraqi Acromegalic Patients. Ibn Al-Haitham Jour. for. Pure & Appl. Sci 2018 May;31(1):172-9. https://doi. org/10.30526/31.1.1864.

[26] Jarvinen VK, Rytomaa II, Heinonen OP. Risk factors in dental erosion. J Dent Res 1991 Jun;70(6):942-7. https://doi.org/10. 1177/00220345910700060601. PMID: 2045572.

[27] Hold K, Douwe de Boer M, Zuidema J. Saliva as an analytical tool in toxicology. Int J Dr T 1999;1(1):1-36. https://www.ojp. gov/ncjrs/virtual-library/abstracts/saliva-analytical-tooltoxicology.

[28] Afredo S, Liacopo C, Lvincenzo C, Giuseppe M, Giannatempo Vincenzo F, Massimo V, et al. Skeletal Involvement in Female Acromegalic Subjects: The Effects of Growth Hormone Excess in Amenorrheal and Menstruating Patients. J Bone Miner Res 1997 October;12(10):1729-36. https://doi.org/10.1359/jbmr.1997.12.10.1729.

[29] Li H, Bartold PM, Young WG, Xiao Y, Waters MJ. Growth hormone induces bone morphogenetic proteins and bonerelated proteins in the developing rat periodontium. J Bone Miner Res 2001 Jun;16(6):1068-76. https://doi.org/10.1359/ jbmr.2001.16.6.1068. PMID: 11393784.

[30] Haase HR, Ivanovski S, Waters MJ, Bartold PM. Growth hormone regulates osteogenic marker mRNA expression in human periodontal fibroblasts and alveolar bone-derived cells. J Periodontal Res 2003 Aug;38(4):366-74. https://doi. org/10.1034/j.1600-0765.2003.00655.x. PMID: 12828652.

[31] Isaksson OG, Ohlsson C, Bengtsson BA, Johannsson G. GH and bone–experimental and clinical studies. Endocr J 2000 Mar;47(Suppl):S9-16. https://doi.org/10.1507/endocrj.47. supplmarch_s9. PMID: 10890175.

[32] Desai S, Shinde H, Mudda J, Patil V. Levels of Alkaline Phosphatase (ALP) In Saliva of Patients with Chronic Periodontitis. Internet J Dent Sci 2009;8(1):1-8. https://www. researchgate.net/publication/357857562_Levels of AlkalinePhosphatase ALP In Saliva of Patients with Chronic Periodontitis a Clinical and Biochemical Study.

[33] Pellegrini GG, Gonzales CM, Somoza JC, Friedman SM, Zeni SN. Correlation between salivary and serum markers of bone turnover in osteopenic rats. J Periodontol 2008 Jan; 79(1):158-65. https://doi.org/10.1902/jop.2008.070168. PMID: 18166106.

[34] Marini A, Cabassi E. Saliva: Complementary approach diagnosis in clinical and biological research. Ann Fac Medic Vet Parma 2002;22:295-311. https://www.istitutostomato logicotoscano.com.